Torrent Pharmaceuticals Limited
TORNTPHARM
Rang in Aktien
#1203
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Aktienkurs
$50.34
Marktkapitalisierung
$19.15B
Veränderung (1 Tag)
-0.07%
Veränderung (1 Jahr)
23.64%
Land
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Kategorie
Healthcare
EPS für Torrent Pharmaceuticals Limited (TORNTPHARM)
EPS zum June 2026 TTM: $0.71
Laut den aktuellen Finanzberichten und dem Aktienkurs von Torrent Pharmaceuticals Limited beträgt das aktuelle EPS des Unternehmens (TTM) $0.71. Am Ende des Jahres 2024 betrug das EPS $0.59 eine Steigerung gegenüber dem EPS von 2023, das $0.45 betrug.
EPS-Verlauf von Torrent Pharmaceuticals Limited von 2005 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $0.71 | 7.76% |
| 2025 | $0.66 | 12.51% |
| 2024 | $0.59 | 31.09% |
| 2023 | $0.45 | 48.00% |
| 2022 | $0.30 | -40.13% |
| 2021 | $0.51 | 25.73% |
| 2020 | $0.40 | 116.54% |
| 2019 | $0.19 | -39.70% |
| 2018 | $0.31 | -27.64% |
| 2017 | $0.43 | -44.97% |
| 2016 | $0.77 | 117.38% |
| 2015 | $0.36 | 8.68% |
| 2014 | $0.33 | 39.00% |
| 2013 | $0.24 | 42.24% |
| 2012 | $0.17 | -7.59% |
| 2011 | $0.18 | 17.75% |
| 2010 | $0.15 | 41.62% |
| 2009 | $0.11 | 7.94% |
| 2008 | $0.10 | 56.20% |
| 2007 | $0.06 | 89.02% |
| 2006 | $0.03 | 2.12% |
| 2005 | $0.03 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -21.78% |
IN
|
